WO2004102176A1 - センサ - Google Patents
センサ Download PDFInfo
- Publication number
- WO2004102176A1 WO2004102176A1 PCT/JP2004/006618 JP2004006618W WO2004102176A1 WO 2004102176 A1 WO2004102176 A1 WO 2004102176A1 JP 2004006618 W JP2004006618 W JP 2004006618W WO 2004102176 A1 WO2004102176 A1 WO 2004102176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- opening
- sensor according
- filter
- sample liquid
- sensor
- Prior art date
Links
- 239000007788 liquid Substances 0.000 claims abstract description 78
- 238000001914 filtration Methods 0.000 claims abstract description 63
- 239000000523 sample Substances 0.000 claims description 74
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 239000003153 chemical reaction reagent Substances 0.000 claims description 31
- 125000006850 spacer group Chemical group 0.000 claims description 21
- 239000012488 sample solution Substances 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 14
- 230000009471 action Effects 0.000 claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 210000000601 blood cell Anatomy 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 13
- 238000005259 measurement Methods 0.000 description 12
- 238000000926 separation method Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 108091006149 Electron carriers Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 6
- 229920001477 hydrophilic polymer Polymers 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 108010055297 Sterol Esterase Proteins 0.000 description 4
- 102000000019 Sterol Esterase Human genes 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- 239000004640 Melamine resin Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 108010023417 cholesterol dehydrogenase Proteins 0.000 description 2
- 150000001840 cholesterol esters Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000005011 phenolic resin Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 239000004645 polyester resin Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 108010085346 steroid delta-isomerase Proteins 0.000 description 2
- 229920005992 thermoplastic resin Polymers 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 229920006337 unsaturated polyester resin Polymers 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920000896 Ethulose Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- GGCLNOIGPMGLDB-GYKMGIIDSA-N cholest-5-en-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GGCLNOIGPMGLDB-GYKMGIIDSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0684—Venting, avoiding backpressure, avoid gas bubbles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0663—Whole sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0874—Three dimensional network
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
Definitions
- the present invention relates to a sensor for quantifying or detecting a specific component in a sample liquid.
- a no sensor As a sensor for detecting a specific component in a sample liquid such as a body fluid, a no sensor is known.
- a biosensor is a sensor that applies a biological material such as a microorganism, an enzyme, an antibody, DNA, or RNA as a molecular identification element.
- the biosensor uses the reactions that occur when the biological material recognizes the specific components, such as the consumption of oxygen by respiration of microorganisms, enzymatic reactions, and luminescence, to determine the specific components contained in the sample solution. Quantify and detect its presence.
- enzyme sensors are being put to practical use. For example, enzyme sensors, which are sensors for glucose, lactic acid, cholesterol, amino acids, etc., are used in medical measurement and the food industry.
- Such an enzyme sensor reduces an electron carrier by electrons generated by a reaction between a specific substance contained in a sample solution and an enzyme, and the amount of reduction of the electron carrier is electrochemically measured by a measuring instrument. Quantify the substrate contained in the sample solution by measuring.
- a configuration is often adopted in which a filtration unit for removing blood cells is provided in the vicinity of an opening to which a sample solution is supplied.
- a filtration unit for removing blood cells is provided in the vicinity of an opening to which a sample solution is supplied.
- the configuration of the filtering unit for example, three systems as shown in (a) to (c) of FIG. 6 have been proposed. At this time, the filtration is performed by a filter provided in the filtration unit.
- FIG. 6 is a schematic diagram showing the horizontal separation method.
- blood which is a sample liquid
- Plasma is exuded from the end (secondary end) where the filtered sample liquid leaks (for example, see WO 02 / 054054A1 pamphlet).
- FIG. 7 is a schematic diagram showing the vertical separation method. In the method shown in this figure, blood is directly dropped onto the primary end of the filter and filtered vertically, causing the plasma to leak from the bottom surface of the secondary end of the filter or the end near it. .
- FIG. 8 is a schematic diagram showing the complex separation method.
- blood is directly dropped onto the primary end of the filter and filtered vertically, and also filtered horizontally, causing plasma to leak from the secondary end of the filter.
- plasma See, for example, WO 02/095385 A1 pamphlet.
- blood cells can be removed before reaching the reaction system by using a suitable filter.
- the sensor using any of Figs. 6 to 8 must drop the sample liquid directly at or near the primary end of the filter, and this configuration causes the following problems.
- the function of the filtration unit is not sufficiently exerted, leading to a decrease in measurement accuracy, a decrease in simultaneous reproducibility, and an increase in measurement time.
- the user needs to keep the sensor substantially horizontal when dropping the sample liquid.
- the blood when a user drops blood from a fingertip, the blood must be dropped exactly at the position where the blood should be dropped. In other words, further improvement is needed from the viewpoint of user operability.
- WO 03 / 074999A1 proposes a biosensor having an inverted truncated cone-shaped sample liquid supply port, but the third problem cannot be solved in this case as well.
- the sample liquid adheres to the inverted truncated cone portion and does not reach the filtration section properly.
- the present invention can quickly and easily supply a sample solution to a filter without keeping it substantially horizontal, and can quickly and simply supply a small amount of sample solution to the filter.
- the purpose is to provide a sensor that can be supplied to the center. Disclosure of the invention
- the present invention relates to a sensor including a filtration unit, a supply unit that supplies a sample liquid to the filtration unit by capillary action, and a reaction unit having a reagent that reacts with the sample liquid filtered by the filtration unit.
- the reaction unit is provided on a substrate, and the supply unit supplies the sample liquid.
- the suction is performed in a substantially horizontal direction with respect to the substrate.
- the filtration unit filters the sample liquid supplied from the supply unit in a direction substantially perpendicular to the substrate.
- the supply means includes: a first opening to which the sample liquid is supplied; a second opening to supply the sample liquid to the filtration unit; and the first opening and the second opening. It is preferable to have a communicating space.
- an air hole is provided in the supply means so that the sample liquid supplied to the first opening is sucked into the second opening.
- the air hole is disposed on a side opposite to the first opening when viewed from the second opening of the supply unit.
- the supply means includes a first cover, a spacer, and a second cover, the second opening is provided in the second cover, and the first opening is provided by the spacer.
- the opening and the air hole are preferably formed.
- the space narrows from the first opening toward the second opening.
- the space narrows from the air hole toward the second opening.
- a distance from the first opening to the second opening is longer than a distance from the second opening to the air hole.
- the maximum width of the second opening is not less than the minimum width of the space.
- the maximum width of the second opening is not more than the distance from the center of the second opening to the air hole.
- the filtration unit filters the sample liquid with a filter, and a cross-sectional area of the second opening is smaller than a cross-sectional area of the filter.
- the cross section of the second opening is similar to the cross section of the filter. Good.
- the volume of the space from the first opening to the second opening is equal to or larger than the sum of the volume of the void of the filter and the volume of the space of the reaction part.
- the reaction section has a second air hole.
- FIG. 1 is an exploded perspective view of a sensor according to one embodiment of the present invention.
- FIG. 2 is a perspective view of a sensor according to one embodiment of the present invention.
- FIG. 3 is a Y-Y sectional view of the sensor according to the embodiment of the present invention.
- FIG. 4 is a schematic view showing a sensor supply unit according to one embodiment of the present invention.
- FIG. 5 is a schematic diagram illustrating a sensor supply unit according to one embodiment of the present invention.
- FIG. 6 is a schematic sectional view of a filter for separating blood by a horizontal separation method.
- FIG. 7 is a schematic sectional view of a filter for separating blood by a vertical separation method.
- FIG. 8 is a schematic cross-sectional view of a filter for separating blood by a complex separation method.
- a sample liquid is supplied to a filtration unit by a supply unit having a predetermined structure and function to be filtered, and the sample liquid filtered by the filtration unit is The sample solution is supplied to a reaction section having a reagent that reacts with the sample solution.
- the sensor 1 includes a supply unit 2, a filtration unit 3, and a reaction unit 4.
- This sensor 1 is greatly different from a conventional sensor in that it has a supply means 2 for supplying a sample liquid to a filtration unit 3. The sample liquid is not directly supplied to the filtration unit, but is supplied to the filtration unit 3 via the supply unit 2.
- the supply means 2 has a capillary structure and supplies the sample liquid to the filtration section 3 by capillary action.
- the ⁇ capillary phenomenon '' means that when a thin tube is placed in a liquid, the liquid surface in the tube becomes higher or lower than other horizontal surfaces due to the effect of the adhesion of the liquid to the inner surface of the tube and the surface tension. Phenomenon.
- the sample solution is quickly supplied to the filtration unit 3 by this capillary action. Since the amount of the sample liquid is determined by the supply means 2, it is possible to prevent an excessive amount of the sample liquid from being supplied to the filtration unit 3. Also, the portion of the filtration unit 3 to which the sample liquid is supplied can be defined by the positional relationship between the supply unit 2 and the filtration unit 3, so that the sample liquid is supplied to an inappropriate location in the filtration unit 3. Can be prevented.
- the reaction with the reagent in the reaction section 4 proceeds appropriately, and the measurement accuracy and the simultaneous reproducibility of the sensor 1 are improved.
- blood including both the case of whole blood and the case of cell-free components such as plasma and serum
- interstitial fluid biological fluids such as skin fluid, sweat, tears, and urine can be used, and glucose, cholesterol, lactic acid, and the like can be used as the test substance in the sample solution.
- sensor 1 is suitable for quantifying cholesterol, glucose, and lactic acid in human blood.
- the configuration of the sensor 1 will be described more specifically taking the quantification of cholesterol contained in the blood of the human body as an example.
- Sensor configuration
- the supply unit 2, the filtration unit 3, and the reaction unit 4 are stacked in this order in the thickness direction of the sensor 1.
- the Z direction shown in the figure is the thickness direction of the sensor 1.
- the X direction is the length direction of the sensor 1
- the Y direction is the width direction of the sensor 1.
- the vertical separation method is adopted as the filtration method.
- the supply means 2 includes a first cover (capillary cover) 20, a second cover (fill cover 1) 2 1, and a second cover 2, in which a second opening 2 3 1 connected to the fill cover is formed. It consists of two spaces (capillaries and spaces).
- the two openings (capillaries) 22 allow a first opening 230 serving as a sample supply unit to be provided between the first cover 20 and the second cover 21.
- An air hole 2 32 and a space 23 having a first opening 2 30 and an air hole 2 32 are formed.
- the supply means 2 has a shape suitable for allowing the sample liquid supplied to the first opening 230 to be sucked into the second opening 231 by capillary action as described later.
- thermoplastic resins such as polyethylene, polystyrene, polyvinyl chloride, polyamide, and saturated polyester resin
- thermosetting resins such as urine resin, melamine resin, phenol resin, epoxy resin, and unsaturated polyester resin, etc. Is mentioned.
- first cover 20, the second cover 21 and the spacer 22 may be formed of the same member, and may be integrally formed.
- the filtration unit 3 is provided between the second cover 21 and the reaction unit cover 40 in which the connection hole 400 for the filter and the second air hole 401 are formed.
- 30 and a columnar filter 31 are arranged.
- the filter spacer 30 has a protruding filter holding section 300 for directly holding the filter 31.
- the filter 31 is held by the filter holding section 300, the second cover 21, and the reaction section cover 40.
- a gap 32 which is a space around the periphery of the filter 31, is formed in a space between the second opening 231, and the connection hole 400. Is done.
- the filter 31 As a material of the filter 31, glass, paper, non-woven fabric of polyester, or the like can be used.
- the size of the hole of the filter 31 is designed so that blood cells do not pass through. More specifically, a sufficient amount of blood that passes through the filter 31 to fill the entire sample liquid supply path 44 described later with plasma, and still does not reach the secondary end of the filter 31
- the size of the pores is designed so that a difference in the flow resistance between the plasma and the blood cells is formed.
- the filter spacer 30 and the filter holder 300 have sufficient rigidity during storage and measurement, similar to the spacer 22 described above. Materials can be used.
- the reaction section 4 includes a reaction section cover 40, a substrate 43, and a reaction section spacer 44.
- a reaction section spacer 44 having a gap is provided between the reaction section cover 40 and the substrate 43 on which a pair of electrodes (electrode system) including the working electrode 41 and the counter electrode 42 are disposed.
- the sample liquid supply path 440 is formed by intervening. That is, the sample liquid supply path 44 is a space formed by the gap of the reaction section spacer 44 and the connection hole 400 of the reaction section cover 40.
- a reagent is arranged in this sample liquid supply path 450.
- the reagent may be arranged as a reagent layer on or near the electrode system. Alternatively, they may be mixed with a conductive material constituting the working electrode 41 and the counter electrode 42 and held inside the electrodes.
- a reagent layer is disposed on the electrode system, it is preferable to form a hydrophilic polymer layer in contact with the reagent layer in order to suppress the separation of the reagent layer.
- a configuration is adopted in which a reagent layer is arranged on an electrode system as described later.
- the substrate 43, the reaction portion spacer 44, and the reaction portion cover 40 are formed of an insulating material such as polyethylene terephthalate.
- an insulating material such as polyethylene terephthalate.
- thermoplastic resins such as polyethylene, polystyrene, polyvinyl chloride, polyamide, and saturated polyester resin
- thermosetting resins such as urea resin, melamine resin, phenol resin, epoxy resin, and unsaturated polyester resin. Resins.
- the working electrode 41 and the counter electrode 42 are formed by sputtering a conductive material such as palladium on the surface of the substrate 43 and then trimming with a laser.
- the electrode area is defined by the pattern shape and the gap provided in the reaction section spacer 44.
- As the working electrode 41 and the counter electrode 42 generally used conductive materials such as palladium, gold, platinum, and carbon can be used.
- the components described above are superimposed in the positional relationship indicated by the dashed line shown in FIG.
- FIG. 2 is a perspective view of the sensor 1 obtained by superimposing in this manner.
- 3 is a sectional view of the sensor 1 taken along line AA in FIG. In FIG. 1, the reagent layer 46 is omitted.
- a reagent layer 46 is arranged in the sample solution supply path 44.
- the reagent layer 46 includes a first reagent layer 460, a second reagent layer 461, and a hydrophilic polymer layer 462 containing a hydrophilic polymer.
- the first reagent layer 460 contains an oxidoreductase and is formed on the lower surface side of the reaction section cover 40.
- the second reagent layer 461 includes an electron carrier, and is formed on the electrode system of the substrate 43. Then, a hydrophilic polymer layer 452 is formed so as to cover the second reagent layer 451.
- the oxidoreductases contained in the first reagent layer 460 include cholesterol oxidase or cholesterol dehydrogenase, an enzyme that catalyzes the cholesterol oxidation reaction, and cholesterol ester to cholesterol. Cholesterol esterase, an enzyme that catalyzes the process, can be used. As a result, the total cholesterol level in plasma can be measured.
- the surfactant include n-butyl octyl-j6-D-thiodarcoside, polyethyleneglycol-l-monododecyl ether, sodium cholate, dodecyl-3-maltoside, diucrose monolaurate, sodium deoxycholate, and taurodeoxychol.
- Sodium acid, N, N-bis (3-D-dalcon amide propyl) deoxycholamide, and polyoxyethylene (10) octyl phenyl ether can be selected.
- Examples of the electron carrier contained in the second reagent layer 461 include, for example, Potassium cyanide, P-benzoquinone, phenazine methosulfate, methylene blue, and phenoctene derivatives, and combinations of two or more of these can be used.
- hydrophilic polymer forming the hydrophilic polymer layer 462 examples include, for example, hydroxyethyl cellulose, hydroxypropyl cellulose, methylcellulose, ethylcellulose, ethylhydroxyethylcellulose, lipoxymethylcellulose, and Polyamino acids such as bierpyrrolidone, polyvinyl alcohol and polylysine, polystyrene sulfonic acid, gelatin and its derivatives, polyacrylic acid and its salts, polymethacrylic acid and its salts, starch and its derivatives, and maleic anhydride Or a polymer of a salt thereof. Of these, carboxymethyl cell mouth, hydroxyethyl cell mouth, and hydroxypropyl cellulose are preferred.
- shape of supply means is preferred.
- FIG. 4 is a diagram when the supply means 2 of the sensor 1 shown in FIGS. 1 to 3 is viewed from above in the direction of arrow Z except for the first cover 20. That is, in FIG. 4, the filter 31 seen from the second cover 21, the two spacers 22, the second opening 2 31, and the second opening 2 31 is recognized.
- the supply means 2 has a tunnel structure including a space 23 having a first opening 2 30 ′ and a second opening 2 31.
- the first opening 2 30 and the air hole 2 32 are located on opposite sides of the supply means 2 from each other.
- the two spacers 22 and the first cover 20 and the second cover 21 form a capillary space that exhibits a capillary phenomenon in a region indicated by A in FIG.
- the second opening 2 3 1 is located below it at the bottom You.
- the sample liquid supplied to the space 23 from the first opening 230 is sucked in the direction toward the air hole 232 and reaches the upper surface of the second opening 231 .
- the upper surface of the second opening 231 is defined by the second opening 231 and the spacer 22 as described later.
- the sample liquid that has reached the second opening 2 31 is supplied to the primary end face of the filter 31 through the second opening 2 31.
- the movement of the sample liquid supplied to the first opening 230 to be sucked into the second opening 231 and supplied to the filter 31 is mainly governed by capillary action.
- the structure of the supply means 2 may be a structure capable of expressing a capillary phenomenon in the region A, but the following conditions (a) to (c) are satisfied. Is preferred.
- the space 23 of the supply means 2 is narrowed from the first opening 230 to the area A.
- the space 23 of the supply means 2 is narrowed from the air hole 232 toward the region A. That is, the shape of the spacer 22 is constricted so that the space 23 becomes narrower from the first opening 230 and the air hole 232 toward the second opening 231. It is preferable to design it.
- the width W1 of the first opening portion 230 and the width W2 of the air hole 232 are preferably larger than the minimum width W3 of the wall in the region A of the space portion 23. Further, it is preferable that the center of the second opening 231 is located at a position where the width of the wall is minimum. As described above, the sample liquid supplied from the first opening 230 to the space 23 is quickly sucked into the second opening 231.
- the distance L 1 from the first opening 230 to the center of the upper surface of the second opening 2 31 is L 1 from the air hole 2 32 to the center of the upper surface of the second opening 2 31. Is preferably not less than L 2. As a result, the sample liquid supplied from the first opening 230 to the space 23 is quickly sucked into the second opening 231.
- the maximum diameter ⁇ 1 of the second opening 23 1 is not less than the minimum width W 3 of the wall in the region ⁇ of the space 23.
- a region A defined by the second opening 231 and the spacer 22 is located on the upper surface of the second opening 231. With such a structure, the sample liquid is quickly supplied to the second opening 231 along the side surface of the wall in the area A, and the sample liquid is supplied only to the outer peripheral portion of the second opening 231. Can be prevented.
- the maximum width ⁇ 1 of the second opening 231 is not more than the distance L2 from the center of the second opening 231 to the air hole 232. If this condition is not satisfied, there is a possibility that the sample liquid entering the second opening 231 may exit from the air hole 232 side due to capillary action.
- the second opening 231, and the filter 31 satisfy the following conditions (d) and (e).
- the area of the second opening 231 is not more than the cross-sectional area of the primary end face of the filter 31.
- the projection (opening) is arranged so as to be included in the filter 31.
- the diameter ⁇ 1 of the second opening 2 31 is smaller than or equal to the diameter 2 of the filter 31.
- the center of the second opening 2 31 and the center of the filter 31 are aligned with each other in the Z-axis direction shown in FIGS. Place. With this arrangement, the sample liquid is reliably supplied to the primary end face of the filter 31. Therefore, it is possible to prevent the sample liquid from reaching the reaction section 4 without being filtered and not passing through the filter 31.
- the shape of the second opening 231, and the cross-sectional shape of the primary end face of the filter 31 are preferably similar. In this embodiment, They are also circular. By doing so, the sample liquid is evenly supplied to the primary end face of the filter 31, and the filtering function of the filter 31 can be fully utilized.
- the suction of the sample liquid by the capillary phenomenon of the supply means 2 and the supply to the filter 31 are performed quickly and accurately. It is preferable to design the supply means 2 so as to satisfy all of the above conditions (a) to (e), but the supply means 2 may be designed to satisfy any one of these conditions. .
- the spacer 22 of the supply means 2 may have a rectangular parallelepiped shape, and the space from the first opening 2 31 to the air hole 23 32 may have a rectangular parallelepiped shape. In this case, the above conditions (b) to (e) are satisfied.
- the volume of the space from the first opening 230 to the portion where the second opening 231 is provided is the volume of the space of the filter 31 and the volume of the reaction part (sample It is preferably equal to or more than the total volume of the space of the liquid supply path 440).
- the supply speed and supply amount of the sample liquid supplied to the filter 31 and the dropping position on the primary end face of the filter 31 can be specified.
- the filtration function of the filter 31 can be fully utilized, and blood cells can be quickly and accurately filtered.
- the user points the blood to the first opening 230 To wear.
- the first opening 230 is located on the side surface of the sensor 1. Therefore, for example, when collecting blood from a fingertip, the fingertip may be brought into contact with the first opening 230 located on the side surface of the sensor 1.
- blood which is a sample liquid
- it is not always necessary to hold the sensor 1 substantially horizontally. Therefore, operability is improved as compared with the conventional case where blood is directly dropped on the filtration unit.
- Blood spotted on the first opening 230 is sucked into the supply means 2 by a capillary phenomenon.
- the blood sucked from the first opening 23 to the direction of the air hole 23 passes through the second opening 231, and passes through the filter 31. From the primary end face, it penetrates into the filter 31 and is filtered in a direction substantially perpendicular to the substrate 43.
- the penetration rate of blood cells is lower than the penetration rate of plasma, which is a liquid component, blood cells are stopped in the filter 31 and plasma seeps out from the secondary end face of the filter.
- the exuded plasma is supplied to the sample solution supply channel 44. This plasma is sucked in the direction from the connection hole 400 to the second air hole 401 by capillary action, and fills the sample solution supply path 450 while dissolving the reagent layer 45. In this state, the blood flow stops.
- Plasma and reagents undergo the following chemical reactions. That is, cholesterol ester in plasma is converted to cholesterol by using cholesterol esterase contained in the first reagent layer 460 as a catalyst. Due to the surfactant contained in the first reagent layer 460, this reaction proceeds quickly. The cholesterol and cholesterol contained in the plasma from the beginning are converted into cholesterone by using cholesterol oxidase or cholesterol dehydrogenase contained in the first reagent layer 400 as a catalyst. At this time, the electron carriers contained in the second reagent layer 461 are reduced. For example, when a ferricyanidation realm is used as the electron carrier, Potassium cyanide is reduced to ferrocyanide lime.
- a voltage is applied between the working electrode 41 and the counter electrode 42 using a measuring device, and the electron carrier is electrochemically oxidized.
- the current value obtained at this time cholesterol in the blood can be quantified.
- the filtration function of the filter 31 can be sufficiently exerted, blood can be quickly and accurately filtered, and blood cells can be stopped in the filter 31, Only the plasma is supplied to the sample liquid supply channel 44. That is, it is possible to prevent blood cells from entering the sample liquid supply path 44. Therefore, the surfactant contained in the first reagent layer 460 can prevent blood cells from being destroyed and prevent a reducing substance such as daltuthione in the blood cells from adversely affecting the reaction. This improves measurement accuracy and simultaneous reproducibility.
- the sensor according to the present invention is not limited to the sensor 1 described in the above embodiment, but supplies a sample liquid to a filtration unit by a supply unit, filters the sample liquid, and combines the sample liquid filtered in the filtration unit with the sample liquid. Any configuration may be used as long as it is supplied to a reaction section having a reacting reagent.
- a reaction section having a reacting reagent any configuration may be used as long as it is supplied to a reaction section having a reacting reagent.
- other components are exemplified.
- the positional relationship between the supply means, the filtration unit, and the reaction unit can be appropriately changed.
- the vertical separation method uses gravity for filtration, so that filtration can be performed quickly because the filtration distance is short, and the effect of the filter on the reaction system because the filter does not enter the sample liquid supply path. Is preferred because of its small size.
- a filtration method such as a horizontal separation method or a composite separation method may be employed by changing the positional relationship between the supply means, the filtration unit, and the reaction unit.
- the supply means may have any structure as long as the sample liquid can be sucked into the filtration unit by capillary action.
- the air holes may be provided in the filtration unit without being provided in the supply means.
- the filtration unit may have a function of filtering the sample liquid.
- a filter When a filter is used, one filter may be used, or two or more filters may be used.
- the shape and material of the filter can also be set appropriately so as not to lower the filtration function.
- oxidoreductase by selecting an appropriate oxidoreductase according to the substance to be measured, it is possible to measure a blood glucose level, a lactic acid level, etc. in addition to cholesterol.
- oxidoreductase dalcos oxidase, fructose dehydrogenase, glucose dehydrogenase, alcohol oxidase, lactate oxidase, cholesterol-loxidase, cholesterol esterase, xanthine oxidase, and amino acid oxidase can be used.
- the electrode system in the reaction section is a two-electrode system, but may be a three-electrode system further including a reference electrode.
- the three-electrode method generally allows more accurate measurement than the two-electrode method.
- the measured substance may be quantified or its presence may be detected by an optical method instead of an electrochemical method.
- a dye that changes color by an enzyme reaction can be used as the reagent. Then, the change in color of the dye may be optically measured to determine the content of the substance to be measured.
- the sample liquid is blood and the substance to be measured is a component in plasma, but the present invention is not limited thereto.
- Measurement targets are not limited to body fluid components such as blood.
- the sensor according to the present invention can be applied to, for example, a measuring device that measures the water quality of lakes and marshes turbid by microorganisms, dead bodies, sludge, and the like.
- an existing portable measuring instrument for example, Horiba Co., Ltd. It can be used by attaching it to the measuring part of a pH meter (manufactured by B-211, etc.).
- the supply means and the filtration section are brought into contact with the water of the turbid lake, whereby the water is sucked and filtered as a sample liquid, and the filtered sample liquid is supplied to the measurement portion (electrode, etc.) of the measuring instrument. can do.
- a suitable quantity of sample liquid can be supplied quickly and easily to a filter.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04732199.7A EP1596190B1 (en) | 2003-05-15 | 2004-05-11 | Sensor |
US10/548,200 US7550290B2 (en) | 2003-05-15 | 2004-05-11 | Sensor |
JP2005506208A JP4208879B2 (ja) | 2003-05-15 | 2004-05-11 | センサ |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-136959 | 2003-05-15 | ||
JP2003136959 | 2003-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004102176A1 true WO2004102176A1 (ja) | 2004-11-25 |
Family
ID=33447242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/006618 WO2004102176A1 (ja) | 2003-05-15 | 2004-05-11 | センサ |
Country Status (5)
Country | Link |
---|---|
US (1) | US7550290B2 (ja) |
EP (1) | EP1596190B1 (ja) |
JP (1) | JP4208879B2 (ja) |
CN (1) | CN100523800C (ja) |
WO (1) | WO2004102176A1 (ja) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
DE60234598D1 (de) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften |
ATE485766T1 (de) | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | Elektrisches betätigungselement für eine lanzette |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
EP1404234B1 (en) | 2001-06-12 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for improving success rate of blood yield from a fingerstick |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
DE60222809T2 (de) * | 2002-03-01 | 2008-06-26 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensor |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
DK1633235T3 (da) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparat til udtagelse af legemsvæskeprøver og detektering af analyt |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND APPARATUS PROVIDING A VARIABLE USER INTERFACE |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
GB0810226D0 (en) * | 2008-06-04 | 2008-07-09 | Weatherley Richard | Blended colour LED lamp |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
EP2473284A1 (en) * | 2009-09-01 | 2012-07-11 | Koninklijke Philips Electronics N.V. | Fluid filtering device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8961007B2 (en) | 2011-03-15 | 2015-02-24 | Siemens Energy, Inc. | Thermocouple and method of forming a thermocouple on a contoured gas turbine engine component |
KR101355127B1 (ko) * | 2011-09-30 | 2014-01-29 | 주식회사 아이센스 | 전기화학적 바이오센서용 산화환원반응 시약조성물 및 이를 포함하는 바이오센서 |
US9188561B2 (en) * | 2013-03-03 | 2015-11-17 | Yue Xu | Test strip |
WO2015020880A2 (en) * | 2013-08-05 | 2015-02-12 | Siemens Healthcare Diagnostics Inc. | Device and method for unit use sensor testing |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01134245A (ja) | 1987-11-19 | 1989-05-26 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JPH07110313A (ja) * | 1993-10-08 | 1995-04-25 | Matsushita Electric Ind Co Ltd | バイオセンサおよびその製造法 |
EP0856586A1 (en) | 1997-01-31 | 1998-08-05 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of manufacturing the same |
JPH11344461A (ja) | 1998-05-29 | 1999-12-14 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2001305093A (ja) * | 2000-04-27 | 2001-10-31 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2002181757A (ja) | 2000-12-11 | 2002-06-26 | Matsushita Electric Ind Co Ltd | バイオセンサおよび基質の測定方法 |
JP2002340839A (ja) * | 2001-05-22 | 2002-11-27 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2003065997A (ja) * | 2001-06-14 | 2003-03-05 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2003075389A (ja) * | 2001-08-31 | 2003-03-12 | Matsushita Electric Ind Co Ltd | アルコール定量用試験片およびアルコールの定量方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE399768B (sv) | 1975-09-29 | 1978-02-27 | Lilja Jan E | Kyvett for provtagning, blandning av, provet med ett reagensmedel och direkt utforande av, serskilt optisk, analys av det med reagensmedlet blandade provet |
US4676274A (en) * | 1985-02-28 | 1987-06-30 | Brown James F | Capillary flow control |
US5726026A (en) * | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
WO2002010735A1 (fr) * | 2000-07-31 | 2002-02-07 | Matsushita Electric Industrial Co., Ltd. | Biocapteur |
JP4183902B2 (ja) | 2000-12-27 | 2008-11-19 | 松下電器産業株式会社 | バイオセンサ |
DE60222809T2 (de) | 2002-03-01 | 2008-06-26 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensor |
-
2004
- 2004-05-11 JP JP2005506208A patent/JP4208879B2/ja not_active Expired - Fee Related
- 2004-05-11 US US10/548,200 patent/US7550290B2/en not_active Expired - Fee Related
- 2004-05-11 EP EP04732199.7A patent/EP1596190B1/en not_active Expired - Fee Related
- 2004-05-11 CN CNB2004800133597A patent/CN100523800C/zh not_active Expired - Fee Related
- 2004-05-11 WO PCT/JP2004/006618 patent/WO2004102176A1/ja active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01134245A (ja) | 1987-11-19 | 1989-05-26 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JPH07110313A (ja) * | 1993-10-08 | 1995-04-25 | Matsushita Electric Ind Co Ltd | バイオセンサおよびその製造法 |
EP0856586A1 (en) | 1997-01-31 | 1998-08-05 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of manufacturing the same |
JPH11344461A (ja) | 1998-05-29 | 1999-12-14 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2001305093A (ja) * | 2000-04-27 | 2001-10-31 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2002181757A (ja) | 2000-12-11 | 2002-06-26 | Matsushita Electric Ind Co Ltd | バイオセンサおよび基質の測定方法 |
JP2002340839A (ja) * | 2001-05-22 | 2002-11-27 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2003065997A (ja) * | 2001-06-14 | 2003-03-05 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2003075389A (ja) * | 2001-08-31 | 2003-03-12 | Matsushita Electric Ind Co Ltd | アルコール定量用試験片およびアルコールの定量方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1596190A4 |
Also Published As
Publication number | Publication date |
---|---|
CN100523800C (zh) | 2009-08-05 |
EP1596190A1 (en) | 2005-11-16 |
EP1596190A4 (en) | 2010-07-07 |
JP4208879B2 (ja) | 2009-01-14 |
CN1791795A (zh) | 2006-06-21 |
US7550290B2 (en) | 2009-06-23 |
EP1596190B1 (en) | 2014-01-29 |
JPWO2004102176A1 (ja) | 2006-07-13 |
US20060099107A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004102176A1 (ja) | センサ | |
JP4120400B2 (ja) | バイオセンサ | |
EP1353169B1 (en) | Biosensor | |
JP5197552B2 (ja) | 液体サンプルの分析のための電気化学式バイオセンサストリップ | |
US6413395B1 (en) | Biosensor apparatus | |
JP4184073B2 (ja) | バイオセンサ | |
US8007645B2 (en) | Biosensor | |
US20100096276A1 (en) | Multicomponent analysis sensor and method of measuring multiple components | |
JPS63128252A (ja) | バイオセンサ | |
WO2007116909A1 (ja) | 試料液分析用パネル | |
JPH11352094A (ja) | 電気化学分析素子 | |
JP4061816B2 (ja) | バイオセンサ | |
JPWO2007052648A1 (ja) | 試料分析用ディスク | |
JPH11304748A (ja) | バイオセンサ | |
RU2278612C2 (ru) | Иммуносенсор | |
JP4639465B2 (ja) | バイオセンサ | |
JP3487410B2 (ja) | バイオセンサ | |
JP2004325384A (ja) | バイオセンサ | |
JP2003254934A (ja) | バイオセンサ | |
JPH01134246A (ja) | バイオセンサ | |
JPH01134242A (ja) | バイオセンサ | |
JP2004194926A (ja) | 体液採取具 | |
Tokunaga et al. | Biosensor | |
Yamanishi et al. | Biosensor | |
Hasegawa et al. | Biosensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004732199 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006099107 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10548200 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005506208 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048133597 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004732199 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10548200 Country of ref document: US |